• Top Quality CAS 115007-34-6 Mycophenolate Mofetil
  • Top Quality CAS 115007-34-6 Mycophenolate Mofetil
  • Top Quality CAS 115007-34-6 Mycophenolate Mofetil
  • Top Quality CAS 115007-34-6 Mycophenolate Mofetil
  • Top Quality CAS 115007-34-6 Mycophenolate Mofetil
  • Top Quality CAS 115007-34-6 Mycophenolate Mofetil

Top Quality CAS 115007-34-6 Mycophenolate Mofetil

Powder: Yes
Customized: Non-Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >99%
Samples:
US$ 25/kg 1 kg(Min.Order)
| Request Sample
Customization:
Gold Member Since 2022

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Function
  • Detailed Photos
  • Related Product
  • Packaging & Shipping
  • Certifications
Overview

Basic Info.

Model NO.
HMJ-Mycophenolate Mofetil
Color
White
Mf
C23h31no7
Einecs
680-628-5
Test
HPLC
MW
433.49
CAS
115007-34-6
Shelf Life
2 Years
Grade
Pharmaceutical Grade
Transport Package
Ziplock Foil Bag. Drum
Specification
1kg Per Foil Bag, 10 Bags Per Carton, 25 Kg Per Dr
Trademark
HMJ
Origin
China
Production Capacity
200kg/Month

Product Description

Top Quality CAS 115007-34-6 Mycophenolate Mofetil

Top Quality CAS 115007-34-6 Mycophenolate Mofetil
Product Description

 

Product Name Top Quality CAS 115007-34-6 Mycophenolate Mofetil
Appearance White powder
Molecular formula C23H31NO7
Molecular weight  433.49
Keywords Powder Mycophenolate Mofetil,Price Mycophenolate Mofetil; Pure Mycophenolate Mofetil
Shelf Life 24 months when properly stored
Storage Keep in a cool, dry, dark location
Function

What is Mycophenolate Mofetil?

Mycophenolate mofetil (MMF), whose trade name is "Cellcept", was developed by the American Syntex Company. It is the semisynthetic derivative of mycophenocli acid (MPA) which is separated out from the glycolysis product of mold Penicillin glaucum. Mycophenolate mofetil is reusable cytostatics who have a history of clinical application being more than 10 years. It is mainly used for the treatment of psoriasis. At late 1980s, animal experiments have confirmed that it can significantly prolong the survival time of the allogeneic transplanted organs such as kidney, heart and islet of rodents. Sollinger et al has successfully applied MMF to the treatment of anti-rejection reaction upon kidney transplant for the first time with a remarkable effect. FDA has approved officially for its registration in 1995 under the trade name "Cellcept", making clinical applications been added into a new and effective immunosuppressant for prevention and treatment of rejection reaction.Chemical PropertiesWhite or almost white, crystalline powder.



Function of Mycophenolate Mofetil

Mainly used to prevent allogeneic organ rejection. Mainly kidney transplantation, but also suitable for heart and liver transplantation, especially refractory rejection after transplantation. Can be used with cyclosporine and corticosteroids at the same time. It can also be applied to autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, primary glomerulonephritis, and psoriasis. Oral: Kidney transplantation: The initial dose is 2 to 3 mg/kg a day, and the maintenance dose is 1 to 2 mg/kg a day, divided into 2 to 3 times. Can be adjusted appropriately according to the condition. Rheumatoid arthritis: 300mg per day.
 

 

Detailed Photos


Top Quality CAS 115007-34-6 Mycophenolate Mofetil

 
Related Product

Top Quality CAS 115007-34-6 Mycophenolate Mofetil

Packaging & Shipping


Top Quality CAS 115007-34-6 Mycophenolate Mofetil

 

Top Quality CAS 115007-34-6 Mycophenolate Mofetil
Certifications

 

Top Quality CAS 115007-34-6 Mycophenolate MofetilTop Quality CAS 115007-34-6 Mycophenolate MofetilTop Quality CAS 115007-34-6 Mycophenolate Mofetil

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now